Search
Close this search box.

Current Good Manufacturing Practices (CGMP) Compliance Issues for Gene Therapy Products

Organization:
United States Pharmacopeial Convention
Department:
NIIMBL Funded:
No
Type:
Professional Development / Training
Relevant Technologies:
Analytical Methods / Technologies
Delivery Modalities:
Online/E-Learning
Type of Enterprise:
Tier 1/Tier 2
Contact:
education@usp.org
Location:
Middle Atlantic
Duration:
0-1 Week
Description:
Phase specific GMPS – Phase I Chain of Custody/Chain of Identity GMPs to ensure patient safety – Phase II and III – Phase 2 and 3 manufacturing will continue to be subject to parts 210 and 211. Visit website for full description

Join Our Mailing List

MailChimp NIIMBL Mailing List Signup
Organization Type
How did you first hear about NIIMBL?